-
Pfizer to buy Array Biopharma for $10.64 bn in cash
expresspharma
June 21, 2019
Pfizer will buy Array Biopharma for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.
-
Pfizer to acquire US company Array BioPharma for $11.4bn
pharmaceutical-technology
June 19, 2019
Pfizer has signed a definitive merger agreement to acquire US-based, commercial-stage biopharmaceutical company Array BioPharma.
-
Pfizer to acquire Array BioPharma in a $11.4B deal
biospectrumasia
June 18, 2019
Proposed acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term
-
Array BioPharma Announces BRAFTOVI + MEKTOVI + Cetuximab Meet Primary Endpoints
americanpharmaceuticalreview
May 22, 2019
Array BioPharma announced positive results from the interim analysis of the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI? (encorafenib), a BRAF inhibitor, MEKTOVI? (binimetinib) ...
-
Array BioPharma collaborates with Pfizer
biospectrumasia
November 19, 2018
Novel combinations of binimetinib (MEK), avelumab (PD-L1), and talazoparib (PARP inhibitor) to be studied across tumor types
-
Array BioPharma Touts Phase III Results for Melanoma Therapy
biospace
March 23, 2018
Shares of?Array BioPharma, Inc.?are climbing this morning after the company released detailed results for its late-stage combination treatment for metastatic melanoma.
-
Array Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics
biospace
December 28, 2017
Array BioPharma?has?spun?out some of its intellectual property and equipment into a new company,?Yarra Therapeutics.?Note that Yarra is Array spelled backwards.
-
Array BioPharma (ARRY) Price Target Increased to $13.00 by Analysts at Jefferies Group
americanbankingnews
December 26, 2017
Array BioPharma (NASDAQ:ARRY)?had its price objective raised by equities research analysts at Jefferies Group to $13.00 in a note issued to investors on Friday
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
